AJAY BANSAL Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for AJAY BANSAL.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of AJAY BANSAL. AJAY BANSAL is in NEKTAR THERAPEUTICS ($NKTR) and CFO, VP Finance & Admin in NEKTAR THERAPEUTICS ($NKTR) and Chief Financial Officer in Onconova Therapeutics, Inc. ($ONTX) and Chief Financial Officer in ViewRay, Inc. ($VRAY) and PFO;CFO/Urovant Sciences, Inc. in Urovant Sciences Ltd. ($UROV).
Latest Insider Trading Transactions of AJAY BANSAL
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, NKTR, ONTX, UROV, VRAY
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 04 2020 | UROV | Urovant Sciences L ... | BANSAL AJAY | PFO;CFO/Urovant Sci ... | Grant | A | 0.00 | 63,659 | 0 | 138,659 | 75 K to 138.7 K (+84.88 %) |
| Nov 05 2019 | UROV | Urovant Sciences L ... | BANSAL AJAY | PFO;CFO/Urovant Sci ... | Option Exercise | A | 9.66 | 140,000 | 1,352,400 | 140,000 | |
| Nov 05 2019 | UROV | Urovant Sciences L ... | BANSAL AJAY | PFO;CFO/Urovant Sci ... | Grant | A | 0.00 | 75,000 | 0 | 75,000 | 0 to 75 K |
| Jul 29 2019 | VRAY | ViewRay, Inc. | BANSAL AJAY | Chief Financial Off ... | Option Exercise | X | 3.17 | 12,519 | 39,685 | 0 | |
| Jul 29 2019 | VRAY | ViewRay, Inc. | BANSAL AJAY | Chief Financial Off ... | Payment of Exercise | F | 9.00 | 4,408 | 39,672 | 98,876 | 103.3 K to 98.9 K (-4.27 %) |
| Jul 29 2019 | VRAY | ViewRay, Inc. | BANSAL AJAY | Chief Financial Off ... | Buy | X | 3.17 | 12,519 | 39,685 | 103,284 | 90.8 K to 103.3 K (+13.79 %) |
| Mar 05 2019 | VRAY | ViewRay, Inc. | BANSAL AJAY | Chief Financial Off ... | Option Exercise | A | 8.47 | 36,038 | 305,242 | 36,038 | |
| Mar 05 2019 | VRAY | ViewRay, Inc. | BANSAL AJAY | Chief Financial Off ... | Grant | A | 0.00 | 20,661 | 0 | 90,765 | 70.1 K to 90.8 K (+29.47 %) |
| Mar 05 2019 | VRAY | ViewRay, Inc. | BANSAL AJAY | Chief Financial Off ... | Option Exercise | A | 8.47 | 36,038 | 305,242 | 36,038 | |
| Mar 05 2019 | VRAY | ViewRay, Inc. | BANSAL AJAY | Chief Financial Off ... | Grant | A | 0.00 | 20,661 | 0 | 90,765 | 70.1 K to 90.8 K (+29.47 %) |
| Apr 18 2018 | VRAY | ViewRay, Inc. | BANSAL AJAY | Chief Financial Off ... | Option Exercise | A | 7.09 | 110,000 | 779,900 | 110,000 | |
| Feb 23 2017 | VRAY | ViewRay, Inc. | BANSAL AJAY | Chief Financial Off ... | Option Exercise | A | 5.05 | 50,000 | 252,500 | 50,000 | |
| Jan 25 2017 | VRAY | ViewRay, Inc. | BANSAL AJAY | Chief Financial Off ... | Option Exercise | A | 4.97 | 103,537 | 514,579 | 103,537 | |
| Jan 20 2017 | VRAY | ViewRay, Inc. | BANSAL AJAY | Chief Financial Off ... | Option Exercise | P | 3.17 | 12,519 | 39,685 | 12,519 | |
| Jan 20 2017 | VRAY | ViewRay, Inc. | BANSAL AJAY | Chief Financial Off ... | Buy | P | 3.17 | 62,597 | 198,432 | 70,104 | 7.5 K to 70.1 K (+833.85 %) |
| Dec 19 2016 | VRAY | ViewRay, Inc. | BANSAL AJAY | Chief Financial Off ... | Grant | A | 0.00 | 7,507 | 0 | 7,507 | 0 to 7.5 K |
| Sep 15 2016 | VRAY | ViewRay, Inc. | BANSAL AJAY | Chief Financial Off ... | Option Exercise | A | 3.58 | 59,832 | 214,199 | 59,832 | |
| Jun 16 2016 | VRAY | ViewRay, Inc. | BANSAL AJAY | Chief Financial Off ... | Option Exercise | A | 4.60 | 550,000 | 2,530,000 | 550,000 | |
| Jan 28 2016 | ONTX | Onconova Therapeut ... | BANSAL AJAY | Chief Financial Off ... | Option Exercise | A | 0.65 | 69,984 | 45,490 | 69,984 | |
| Oct 01 2015 | ONTX | Onconova Therapeut ... | BANSAL AJAY | Chief Financial Off ... | Option Exercise | A | 1.48 | 32,500 | 48,100 | 32,500 | |
| Apr 20 2015 | ONTX | Onconova Therapeut ... | BANSAL AJAY | Chief Financial Off ... | Option Exercise | A | 2.32 | 32,500 | 75,400 | 32,500 | |
| Mar 09 2006 | NKTR | NEKTAR THERAPEUTIC ... | BANSAL AJAY | Option Exercise | D | 0.01 | 8,333 | 83 | 20,501 | ||
| Mar 09 2006 | NKTR | NEKTAR THERAPEUTIC ... | BANSAL AJAY | Grant | A | 0.01 | 8,333 | 83 | 10,333 | 2 K to 10.3 K (+416.65 %) | |
| Mar 13 2006 | NKTR | NEKTAR THERAPEUTIC ... | BANSAL AJAY | Sell | S | 20.01 | 300 | 6,003 | 5,166 | 5.5 K to 5.2 K (-5.49 %) | |
| Mar 13 2006 | NKTR | NEKTAR THERAPEUTIC ... | BANSAL AJAY | Sell | S | 19.88 | 500 | 9,940 | 5,466 | 6 K to 5.5 K (-8.38 %) | |
| Mar 13 2006 | NKTR | NEKTAR THERAPEUTIC ... | BANSAL AJAY | Sell | S | 19.89 | 1,000 | 19,890 | 5,966 | 7 K to 6 K (-14.36 %) | |
| Mar 13 2006 | NKTR | NEKTAR THERAPEUTIC ... | BANSAL AJAY | Sell | S | 19.98 | 800 | 15,984 | 6,966 | 7.8 K to 7 K (-10.30 %) | |
| Mar 13 2006 | NKTR | NEKTAR THERAPEUTIC ... | BANSAL AJAY | Sell | S | 19.85 | 100 | 1,985 | 7,766 | 7.9 K to 7.8 K (-1.27 %) | |
| Mar 13 2006 | NKTR | NEKTAR THERAPEUTIC ... | BANSAL AJAY | Sell | S | 19.90 | 300 | 5,970 | 7,866 | 8.2 K to 7.9 K (-3.67 %) | |
| Mar 13 2006 | NKTR | NEKTAR THERAPEUTIC ... | BANSAL AJAY | Sell | S | 19.92 | 300 | 5,976 | 8,166 | 8.5 K to 8.2 K (-3.54 %) | |
| Mar 13 2006 | NKTR | NEKTAR THERAPEUTIC ... | BANSAL AJAY | Sell | S | 19.97 | 100 | 1,997 | 8,466 | 8.6 K to 8.5 K (-1.17 %) | |
| Mar 13 2006 | NKTR | NEKTAR THERAPEUTIC ... | BANSAL AJAY | Sell | S | 20.00 | 400 | 8,000 | 8,566 | 9 K to 8.6 K (-4.46 %) | |
| Mar 13 2006 | NKTR | NEKTAR THERAPEUTIC ... | BANSAL AJAY | Sell | S | 19.86 | 600 | 11,916 | 8,966 | 9.6 K to 9 K (-6.27 %) | |
| Mar 13 2006 | NKTR | NEKTAR THERAPEUTIC ... | BANSAL AJAY | Sell | S | 19.87 | 467 | 9,279 | 9,566 | 10 K to 9.6 K (-4.65 %) | |
| Mar 13 2006 | NKTR | NEKTAR THERAPEUTIC ... | BANSAL AJAY | Sell | S | 19.94 | 200 | 3,988 | 10,033 | 10.2 K to 10 K (-1.95 %) | |
| Mar 13 2006 | NKTR | NEKTAR THERAPEUTIC ... | BANSAL AJAY | Sell | S | 20.04 | 100 | 2,004 | 10,233 | 10.3 K to 10.2 K (-0.97 %) | |
| Mar 07 2006 | NKTR | NEKTAR THERAPEUTIC ... | BANSAL AJAY | Option Exercise | D | 0.01 | 2,000 | 20 | 28,834 | ||
| Mar 07 2006 | NKTR | NEKTAR THERAPEUTIC ... | BANSAL AJAY | Grant | A | 0.01 | 2,000 | 20 | 2,000 | 0 to 2 K | |
| Sep 07 2005 | NKTR | NEKTAR THERAPEUTIC ... | BANSAL AJAY | CFO, VP Finance & A ... | Option Exercise | D | 5.43 | 3,000 | 16,287 | 95,500 | |
| Sep 07 2005 | NKTR | NEKTAR THERAPEUTIC ... | BANSAL AJAY | CFO, VP Finance & A ... | Sell | S | 19.96 | 3,000 | 59,880 | 0 | 3 K to 0 (-100.00 %) |
| Sep 07 2005 | NKTR | NEKTAR THERAPEUTIC ... | BANSAL AJAY | CFO, VP Finance & A ... | Buy | M | 5.43 | 3,000 | 16,287 | 0 | -3,000 to 0 (-100.00 %) |
| May 17 2005 | NKTR | NEKTAR THERAPEUTIC ... | BANSAL AJAY | CFO, VP Finance & A ... | Option Exercise | D | 0.00 | 4,166 | 0 | 30,834 | |
| May 17 2005 | NKTR | NEKTAR THERAPEUTIC ... | BANSAL AJAY | CFO, VP Finance & A ... | Sell | S | 16.41 | 4,166 | 68,384 | 0 | 4.2 K to 0 (-100.00 %) |
| May 17 2005 | NKTR | NEKTAR THERAPEUTIC ... | BANSAL AJAY | CFO, VP Finance & A ... | Grant | A | 0.00 | 4,166 | 0 | 4,166 | 0 to 4.2 K |
| Feb 11 2005 | NKTR | NEKTAR THERAPEUTIC ... | BANSAL AJAY | CFO, VP Finance & A ... | Option Exercise | A | 0.01 | 10,000 | 100 | 0 | |
| Feb 11 2005 | NKTR | NEKTAR THERAPEUTIC ... | BANSAL AJAY | CFO, VP Finance & A ... | Option Exercise | A | 18.54 | 20,000 | 370,800 | 0 | |
| Jan 05 2005 | NKTR | NEKTAR THERAPEUTIC ... | BANSAL AJAY | CFO, VP Finance & A ... | Option Exercise | D | 5.43 | 7,000 | 38,003 | 78,500 | |
| Jan 05 2005 | NKTR | NEKTAR THERAPEUTIC ... | BANSAL AJAY | CFO, VP Finance & A ... | Sell | S | 20.06 | 7,000 | 140,420 | 25,000 | 32 K to 25 K (-21.87 %) |
| Jan 05 2005 | NKTR | NEKTAR THERAPEUTIC ... | BANSAL AJAY | CFO, VP Finance & A ... | Buy | M | 5.43 | 7,000 | 38,003 | 25,000 | 18 K to 25 K (+38.89 %) |
| Dec 01 2004 | NKTR | NEKTAR THERAPEUTIC ... | BANSAL AJAY | CFO, VP Finance & A ... | Option Exercise | D | 5.43 | 1,500 | 8,144 | 85,500 | |
| Dec 01 2004 | NKTR | NEKTAR THERAPEUTIC ... | BANSAL AJAY | CFO, VP Finance & A ... | Buy | S | 20.00 | 1,500 | 30,000 | 25,000 | 23.5 K to 25 K (+6.38 %) |
| Dec 01 2004 | NKTR | NEKTAR THERAPEUTIC ... | BANSAL AJAY | CFO, VP Finance & A ... | Buy | M | 5.43 | 1,500 | 8,144 | 25,000 | 23.5 K to 25 K (+6.38 %) |
| Mar 08 2004 | NKTR | NEKTAR THERAPEUTIC ... | BANSAL AJAY | CFO, VP Finance & A ... | Option Exercise | D | 5.06 | 3,000 | 15,188 | 87,000 | |
| Mar 08 2004 | NKTR | NEKTAR THERAPEUTIC ... | BANSAL AJAY | CFO, VP Finance & A ... | Sell | S | 21.80 | 1,000 | 21,800 | 25,000 | 26 K to 25 K (-3.85 %) |
| Mar 08 2004 | NKTR | NEKTAR THERAPEUTIC ... | BANSAL AJAY | CFO, VP Finance & A ... | Sell | S | 21.97 | 2,000 | 43,940 | 25,000 | 27 K to 25 K (-7.41 %) |
| Mar 08 2004 | NKTR | NEKTAR THERAPEUTIC ... | BANSAL AJAY | CFO, VP Finance & A ... | Buy | M | 5.06 | 3,000 | 15,188 | 25,000 | 22 K to 25 K (+13.64 %) |
| Mar 03 2004 | NKTR | NEKTAR THERAPEUTIC ... | BANSAL AJAY | CFO, VP Finance & A ... | Grant | A | 0.01 | 25,000 | 250 | 25,000 | 0 to 25 K |
| Mar 03 2004 | NKTR | NEKTAR THERAPEUTIC ... | BANSAL AJAY | CFO, VP Finance & A ... | Grant | A | 0.01 | 25,000 | 250 | 25,000 | 0 to 25 K |
Page: 1